Downstream processing of polymer-based amorphous solid dispersions to generate tablet formulations
Application of amorphous solid dispersions (ASDs) is considered one of the most promising
approaches to increase the dissolution rate and extent of bioavailability of poorly water …
approaches to increase the dissolution rate and extent of bioavailability of poorly water …
An update on microcrystalline cellulose in direct compression: Functionality, critical material attributes, and co-processed excipients
H Zhao, L Zhao, X Lin, L Shen - Carbohydrate Polymers, 2022 - Elsevier
Microcrystalline cellulose (MCC) is one of the most popular cellulose derivatives in the
pharmaceutical industry. Thanks to its outstanding tabletability, MCC is generally included in …
pharmaceutical industry. Thanks to its outstanding tabletability, MCC is generally included in …
Co-proccessed excipients with enhanced direct compression functionality for improved tableting performance
J Rojas, I Buckner, V Kumar - Drug development and industrial …, 2012 - Taylor & Francis
It is necessary to have excipients with excellent functional properties to compensate for the
poor mechanical properties and low aqueous solubility of the emerging active ingredients …
poor mechanical properties and low aqueous solubility of the emerging active ingredients …
Multifunctional coprocessed excipients for improved tabletting performance
S Saha, AF Shahiwala - Expert opinion on drug delivery, 2009 - Taylor & Francis
With the advancement of tablet manufacturing process, the demand of excipients with
improved functionalities, mainly in terms of flow and compression properties, has increased …
improved functionalities, mainly in terms of flow and compression properties, has increased …
Co-processed excipients: Recent advances and future perspective
The demands on the functionality of excipients are increasing day by day because of the
emergence of high-speed tableting machines and the use of direct compression methods for …
emergence of high-speed tableting machines and the use of direct compression methods for …
Co-processed excipients for dispersible tablets–part 1: Manufacturability
BJ Bowles, K Dziemidowicz, FL Lopez, M Orlu… - AAPS …, 2018 - Springer
Co-processed excipients may enhance functionality and reduce drawbacks of traditional
excipients for the manufacture of tablets on a commercial scale. The following study aimed …
excipients for the manufacture of tablets on a commercial scale. The following study aimed …
Spray drying for direct compression of pharmaceuticals
Tableting by direct compression (DC) is one of the simplest and most cost-effective drug
manufacturing approaches. However, most active pharmaceutical ingredients (APIs) and …
manufacturing approaches. However, most active pharmaceutical ingredients (APIs) and …
Formulation of Ebastine Fast‐Disintegrating Tablet Using Coprocessed Superdisintegrants and Evaluation of Quality Control Parameters
B Dhakal, JK Thakur, RK Mahato… - The Scientific World …, 2022 - Wiley Online Library
Ebastine is a long‐acting, nonsedating, second‐generation antihistaminic drug that prevents
histamine action, mainly in immediate hypersensitivity. This project was aimed to formulate …
histamine action, mainly in immediate hypersensitivity. This project was aimed to formulate …
Development and pharmaceutical performance of a novel co-processed excipient of alginic acid and microcrystalline cellulose
R Benabbas, NM Sanchez-Ballester, B Bataille… - Powder technology, 2021 - Elsevier
In this study, a co-processed excipient (Cop AA-MCC) was prepared from alginic acid (AA)
and microcrystalline cellulose (MCC101) using a laboratory scale high-shear granulator …
and microcrystalline cellulose (MCC101) using a laboratory scale high-shear granulator …
[PDF][PDF] A review on co-processed excipients: current and future trend of excipient technology
There is no single-component excipient fulfills all the requisite performance to allow an
active pharmaceutical ingredient to be formulated into a specific dosage form. Co-processed …
active pharmaceutical ingredient to be formulated into a specific dosage form. Co-processed …